IDH1 and neoplasm: C5 exhibits fewer tumor-associated immune cells and better outcome, with the enriched CpG island methylator phenotype-high (CIMP-H), the 1p/19q codeletion and pilocytic astrocytoma-like (PA-like) as well as the IDH mutations.